13F-HR filed by Opaleye Management Inc.
Opaleye Management Inc. filed this 13F-HR for the quarter ended 2013-12-31, filed 2014-02-14, with 23 holding rows worth $127,387,015.
- Accession
- 0001546927-14-000060
- Filer
- CIK 1595855
- Filed
- 2014-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2013
A holdings report, 23 entries on the cover page, a total value of $127,387,015 stated on the cover page (in dollars after the unit check, H1), rows summing to $127,387,015 with VALUE read as dollars, detected, 13F file number 028-15896. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GENTIUM S P A | 37250B104 | SPONSORED ADR | 505,000 | $29,239,500 | dollars, detected | |
| GERON CORP | 374163103 | COM | 2,640,000 | $13,200,000 | dollars, detected | |
| PHARMACYCLICS INC | 716933106 | COM | 120,000 | $12,960,000 | dollars, detected | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 1,670,000 | $11,857,000 | dollars, detected | |
| NPS PHARMACEUTICALS INC | 62936P103 | COM | 205,000 | $5,945,000 | dollars, detected | |
| OMEROS CORP | 682143102 | COM | 460,000 | $5,060,000 | dollars, detected | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 132,500 | $5,035,000 | dollars, detected | |
| LIGAND PHARMACEUTICALS INC | 53220K504 | COM NEW | 90,000 | $4,860,000 | dollars, detected | |
| CEMPRA INC | 15130J109 | COM | 365,000 | $4,745,000 | dollars, detected | |
| CARDIOVASCULAR SYSTEMS INC | 141619106 | COMMON STOCK | 135,000 | $4,455,000 | dollars, detected | |
| SUNSHINE HEART INC | 86782u106 | COM | 425,100 | $4,123,470 | dollars, detected | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 56,900 | $3,641,600 | dollars, detected | |
| INSPIREMD INC | 45779A309 | COM | 1,134,400 | $2,949,440 | dollars, detected | |
| NOVADAQ TECHNOLOGIES INC COMMON | 66987G102 | COM | 167,600 | $2,849,200 | dollars, detected | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 1,353,900 | $2,640,105 | dollars, detected | |
| CELGENE CORP | 151020112 | RIGHT 12/31/2030 | 800,000 | $2,240,000 | dollars, detected | |
| BIND THERAPEUTICS INC | 05548N107 | Cmn | 155,000 | $2,123,500 | dollars, detected | |
| BIOLINERX LTD-SPONS ADR | 09071M106 | SPON | 713,000 | $2,067,700 | dollars, detected | |
| TETRAPHASE PHARMACEUTICALS INC | 88165N105 | COMMON STOCK | 153,500 | $1,995,500 | dollars, detected | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 130,000 | $1,670,500 | dollars, detected | |
| MEDIVATION INC | 58501N101 | COM | 25,000 | $1,600,000 | dollars, detected | |
| KALOBIOS PHARMACEUTICALS INC | 48344T100 | COM | 285,000 | $1,168,500 | dollars, detected | |
| CELATOR PHARMACEUTICALS INC | 15089R102 | Cmn | 310,000 | $961,000 | dollars, detected |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001546927-14-000060 | this filing | 2014-02-14 | acceptance time not in the bulk data set |